Budesonide Caps
designed to support gut health by reducing inflammation in the gastrointestinal tract.
Strengths: 3mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Entocort; Budenofalk
- Therapeutic class
Corticosteroid
- Pharmacological class
Corticosteroid
- Contraindications
hypersensitivity to budesonide; severe hepatic impairment
- Minor side effects
nausea; abdominal pain; headache; fatigue
- Moderate side effects
cushingoid features; decreased bone density; fluid retention
- Dosage forms
Capsule, hard
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
AstraZeneca
- Onset Time
2–4 weeks
- Duration
short-term courses
- Storage instructions
Keep container tightly closed below 25°C.
- Drug interactions
grapefruit juice; strong CYP3A4 inhibitors
- Age restrictions
Consult specialist for paediatric use.
Precautions and warnings
avoid eating grapefruit while taking this medication; do not chew or crush capsules; monitor for signs of infection
Serious side effects
severe infection — requires immediate medical attention; psychiatric disturbances — requires immediate medical attention
Patient summary
designed to support gut health by reducing inflammation in the gastrointestinal tract.
Mechanism of action
This formulation utilizes a controlled-release mechanism to deliver the corticosteroid directly to the site of inflammation in the ileum and colon, reducing systemic absorption while effectively suppressing the local immune response.
Pregnancy and breastfeeding
Pregnancy: Use only if the therapeutic benefit justifies the risk. Breastfeeding: Exercise caution.
Budesonide Caps
designed to support gut health by reducing inflammation in the gastrointestinal tract.
Editorial Notes
- Active ingredient(s): Budesonide
- Listed indication(s): Crohn’s Disease, Ulcerative Colitis
Available option
- 90 tablets - 3 mg1204-3-mg-14273